MeSH term
Frequency | Condition_Probility | Alleles | 3 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Chromosomes, Human, Pair 6 | 4 | 2.0 |
Cleft Lip/*genetics | 3 | 4.0 |
Cleft Palate/*genetics | 3 | 4.0 |
Genetic Markers | 2 | 0.0 |
Humans | 23 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 19 | 0.0 |
Aged | 3 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Cell Line | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
Female | 12 | 0.0 |
Introns | 2 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Exons | 2 | 0.0 |
Genotype | 4 | 0.0 |
Phenotype | 3 | 0.0 |
Animals | 7 | 0.0 |
Chromosomes, Human, Pair 4/genetics | 2 | 2.0 |
Endothelin-1/*genetics | 5 | 55.0 |
Lod Score | 2 | 0.0 |
Mice | 4 | 0.0 |
Mutation | 2 | 0.0 |
Adult | 4 | 0.0 |
Comparative Study | 2 | 0.0 |
Gene Frequency | 3 | 0.0 |
Japan | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 4 | 0.0 |
Endothelin-1 | 3 | 27.0 |
Endothelins/*genetics | 8 | 66.0 |
Molecular Sequence Data | 5 | 0.0 |
Protein Precursors/*genetics | 3 | 2.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
*Polymorphism, Genetic | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Deoxyribonucleases, Type II Site-Specific | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Infant | 2 | 0.0 |
Syndrome | 2 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Mesoderm/metabolism | 2 | 2.0 |
